血浆置换市场规模、份额和成长分析（按产品、技术、流程、应用、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，血浆置换市场规模将达到 13.4 亿美元，到 2025 年将达到 14.4 亿美元，到 2033 年将达到 26 亿美元，在预测期（2026-2033 年）内，复合年增长率为 7.7%。

受多种宏观经济和微观经济因素的驱动，全球血浆置换疗法市场预计将迎来显着成长。医疗费用支出不断增长，尤其是在中东和亚太地区，为专注于先进医疗技术的市场相关人员创造了新的机会。人们对重症肌无力、全身性红斑性狼疮等免疫系统疾病治疗方案的认识不断提高，进一步推动了市场需求。血浆置换技术的进步及其在兽医领域的拓展预计将对市场格局产生正面影响。环境因素和人口成长导致自体免疫疾病盛行率上升，推动血浆置换服务需求达到两位数成长。北美目前占据领先的市场份额，并在未来几年拥有巨大的成长潜力。

血浆置换市场驱动因素

血浆置换市场预计将持续成长，其主要驱动力是血栓性血小板低下紫斑症、Guillain-Barré二氏症候群和重症肌无力等多种自体免疫疾病的日益普遍。人们对这些疾病的认识不断提高，加上对加强医疗基础设施建设的日益重视，预计将进一步推动对血浆置换的需求。多个地区对医疗保健领域的投资不断增加，也有助于推动先进治疗方法的应用。尤其是在中东和非洲以及亚太地区，医疗领域的进步预计将在推动对创新医疗解决方案的需求方面发挥关键作用，从而进一步促进血浆置换市场的成长。

血浆交换市场的限制

由于人们对血浆置换疗法潜在副作用的担忧，该疗法市场面临显着挑战。患者可能会出现血压下降、心律不整、体温暂时升高、麻木或瘫痪等症状。虽然这些副作用通常被认为是轻微的，但它们可能会显着影响医疗服务提供者和患者接受血浆置换疗法作为可行治疗方案的意愿。因此，市场相关人员可能会面临血浆置换疗法利用率低的问题，这可能会阻碍市场的整体成长和推广。

血浆置换市场趋势

由于贫血、胃肠道疾病和癌症等慢性疾病的日益普遍，对血浆衍生疗法的需求不断增长，血浆置换市场正经历显着增长。这种需求的激增进一步推动了高效捐血方法的发展。医疗机构正积极创新和改进血浆分离设备，特别是血浆分离机，以提高该疗法的有效性和安全性。此外，患者和医护人员对血浆置换益处的认识不断提高，也促进了其广泛应用。总而言之，这些趋势预示着全球血浆置换市场将呈现强劲的成长动能。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球血浆置换市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 装置
• 消耗品

全球血浆置换市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 薄膜过滤
• 离心

全球血浆置换市场规模（按手术类型和复合年增长率划分）（2026-2033 年）

• 光化学疗法
• 低密度脂蛋白血浆置换术
• 血小板分离方法
• 白血球分离术
• 红血球分离术

全球血浆置换市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 原始血浆采集
• 治疗性血浆置换疗法
• 免疫学
• 神经病学
• 血液学
• 重症监护
• 肿瘤学
• 风湿病学和整形外科
• 其他治疗用途

全球血浆置换市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 血库和血浆采集中心
• 医院和诊所
• 生物製药公司
• 其他最终用户

全球血浆置换市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• CSL Limited（Australia）
• Takeda Pharmaceutical Company Limited（Japan）
• Grifols, SA（Spain）
• Baxter International Inc.（United States）
• Kedrion SpA（Italy）
• Octapharma AG（Switzerland）
• Asahi Kasei Medical Co., Ltd.（Japan）
• B. Braun Melsungen AG（Germany）
• Fresenius SE & Co. KGaA（Germany）
• Terumo BCT, Inc.（United States）
• Haemonetics Corporation（United States）
• Cerus Corporation（United States）
• Nikkiso Co., Ltd.（Japan）
• Kawasumi Laboratories, Inc.（Japan）
• Macopharma SA（France）
• Shanghai RAAS Blood Products Co., Ltd.（China）
• China Biologic Products Holdings, Inc.（China）
• LFB SA（France）
• Bio Products Laboratory Ltd.（United Kingdom）
• Sanquin Blood Supply Foundation（Netherlands）

结论与建议

Plasmapheresis Market size was valued at USD 1.34 Billion in 2024 and is poised to grow from USD 1.44 Billion in 2025 to USD 2.6 Billion by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).

The global plasmapheresis market is poised for significant growth, driven by various macroeconomic and microeconomic factors. Increasing healthcare expenditures, particularly in regions like the Middle East and Asia Pacific, are creating new opportunities for market players, emphasizing advanced medical care. A growing awareness of treatment options for immune system disorders such as myasthenia gravis and systemic lupus erythematosus is further propelling market demand. Advances in plasmapheresis technology and the expansion into veterinary healthcare are expected to positively influence the market landscape. With autoimmune diseases becoming more prevalent due to environmental factors and population growth, plasmapheresis services are experiencing double-digit demand increases. The North American sector leads in market share and offers substantial growth potential in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Plasmapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Plasmapheresis Market Segments Analysis

Global Plasmapheresis Market is segmented by product, technology, procedure, application, end user and region. Based on product, the market is segmented into instruments and disposables. Based on technology, the market is segmented into membrane filtration and centrifugation. Based on procedure, the market is segmented into photopheresis, Ldl apheresis, plateletpheresis, leukapheresis and erythrocytapheresis. Based on application, the market is segmented into source plasma collection, therapeutic plasmapheresis, immunology, neurology, hematology, critical care, oncology, rheumatology & orthopedics and other therapeutic applications. Based on end user, the market is segmented into blood banks & plasma collection centers, hospital & clinics, biopharmaceutical companies and other end user. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Plasmapheresis Market

The plasmapheresis market is poised for growth driven by an increase in the prevalence of various autoimmune disorders, such as thrombotic thrombocytopenic purpura, Guillain-Barre syndrome, Myasthenia gravis, and others. As awareness of these conditions rises, coupled with an emphasis on enhancing healthcare infrastructure, the demand for plasmapheresis therapy is expected to escalate. The growing investment in healthcare across multiple regions is supporting the wider adoption of advanced treatment options. In particular, developments in regions like the Middle East and Africa, along with Asia Pacific, are likely to play a significant role in driving the demand for innovative healthcare solutions, further boosting the plasmapheresis market.

Restraints in the Plasmapheresis Market

The plasmapheresis market faces notable challenges stemming from concerns related to potential side effects associated with the procedure. Patients may experience issues such as decreased arterial blood pressure, irregular heart rhythms, temporary increases in body temperature, and sensations of tingling or numbness. Although these adverse effects are generally considered mild, they can significantly impact the willingness of healthcare providers and patients to embrace plasmapheresis as a viable treatment option. As a result, stakeholders in the market may encounter hurdles related to declining usage rates of plasmapheresis therapies, which could hinder overall market growth and adoption efforts.

Market Trends of the Plasmapheresis Market

The plasmapheresis market is experiencing significant growth as the demand for plasma-derived therapies rises, driven by an increasing prevalence of chronic diseases such as anemia, gastrointestinal disorders, and cancer. This surge is further propelling the need for efficient blood donation practices. Healthcare organizations are actively innovating and enhancing plasmapheresis equipment, particularly apheresis machines, aiming to improve the efficacy and safety of the procedure. Furthermore, the growing awareness among patients and healthcare professionals about the benefits of plasmapheresis is contributing to its wider acceptance. Overall, these dynamics indicate a robust expansion trajectory for the plasmapheresis market globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Plasmapheresis Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Disposables

Global Plasmapheresis Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Membrane Filtration
• Centrifugation

Global Plasmapheresis Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Photopheresis
• Ldl Apheresis
• Plateletpheresis
• Leukapheresis
• Erythrocytapheresis

Global Plasmapheresis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Source Plasma Collection
• Therapeutic Plasmapheresis
• Immunology
• Neurology
• Hematology
• Critical Care
• Oncology
• Rheumatology & Orthopedics
• Other Therapeutic Applications

Global Plasmapheresis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Blood Banks & Plasma Collection Centers
• Hospital & Clinics
• Biopharmaceutical Companies
• Other End User

Global Plasmapheresis Market Size & CAGR (2026-2033)

• North America (Product, Technology, Procedure, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Procedure, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Procedure, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Procedure, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Procedure, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kedrion S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octapharma AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai RAAS Blood Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Biologic Products Holdings, Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LFB S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Products Laboratory Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanquin Blood Supply Foundation (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations